The efficacy and safety of tazobactam/ceftolozane in Japanese patients with uncomplicated pyelonephritis and complicated urinary tract infection

We report efficacy and safety results for a combination of a novel cephalosporin class antibiotic and a β-Lactamase inhibitor, tazobactam/ceftolozane (1:2) at a dose of 1.5 g intravenously every 8 h in Japanese patients with uncomplicated pyelonephritis and complicated urinary tract infection. This...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy 2019-02, Vol.25 (2), p.104-110
Hauptverfasser:	Arakawa, Soichi, Kawahara, Kazuya, Kawahara, Motoshi, Yasuda, Mitsuru, Fujimoto, Go, Sato, Asako, Yokokawa, Ruriko, Yoshinari, Tomoko, Rhee, Elizabeth G., Aoyama, Norihiro
Format:	Artikel
Sprache:	eng
Schlagworte:	Bacterial count Ceftolozane ESBL Japanese patient Pyelonephritis Urinary tract infection
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!